Post by Rebrain.

2,754 followers

๐ŸŽ‰๐—ฅ๐—ฒ๐—ฏ๐—ฟ๐—”๐—œ๐—ป ๐—ฎ๐—ฐ๐—ต๐—ถ๐—ฒ๐˜ƒ๐—ฒ๐˜€ ๐— ๐——๐—ฅ ๐—–๐—ฒ๐—ฟ๐˜๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ! ๐ŸŽ‰ Weโ€™re thrilled to announce thatย RebrAInย has officially securedย ๐—–๐—˜ ๐—บ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐—ด ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ ๐˜๐—ต๐—ฒ ๐—ป๐—ฒ๐˜„ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐Ÿฎ๐Ÿฌ๐Ÿญ๐Ÿณ/๐Ÿณ๐Ÿฐ๐Ÿฑ)ย for bothย itsย ๐—ข๐—ฝ๐˜๐—ถ๐—บ๐— ๐—ฅ๐—œ ๐˜€๐—ผ๐—ณ๐˜๐˜„๐—ฎ๐—ฟ๐—ฒย andย itsย ๐—ค๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† ๐— ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ฆ๐˜†๐˜€๐˜๐—ฒ๐—บ (QMS)ย โ€” a major milestone in our mission to advance precision neurosurgery for patients living withย ๐—ฃ๐—ฎ๐—ฟ๐—ธ๐—ถ๐—ป๐˜€๐—ผ๐—ปโ€™๐˜€ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ฒ๐˜€๐˜€๐—ฒ๐—ป๐˜๐—ถ๐—ฎ๐—น ๐˜๐—ฟ๐—ฒ๐—บ๐—ผ๐—ฟ. ๐Ÿ”นย Alreadyย ๐—™๐——๐—”-๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—ฒ๐—ฑย in 2024, our service is now fullyย marketable inย ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—จ๐—ฆ๐—”,ย for bothย ๐——๐—ฒ๐—ฒ๐—ฝ ๐—•๐—ฟ๐—ฎ๐—ถ๐—ป ๐—ฆ๐˜๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ปย (DBS)ย andย ๐—น๐—ฒ๐˜€๐—ถ๐—ผ๐—ป๐—ถ๐—ป๐—ด ๐—ฝ๐—ฟ๐—ผ๐—ฐ๐—ฒ๐—ฑ๐˜‚๐—ฟ๐—ฒ๐˜€ย (HIFU & Radiosurgery). ๐Ÿ”นOur platform helps surgical teams refine targeting and improve clinical outcomes through AI algorithms trained on real patient data. โœจThis recognition is more than a regulatory step โ€” itโ€™s a statement of our commitment toย ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฟ๐—ถ๐—ด๐—ผ๐—ฟ, ๐—ฑ๐—ฎ๐˜๐—ฎ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป, and improving lives throughย ๐—ป๐—ฒ๐˜…๐˜-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ป๐—ฒ๐˜‚๐—ฟ๐—ผ๐˜€๐˜‚๐—ฟ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ผ๐—ผ๐—น๐˜€. ๐Ÿ”—ย For more information, visitย ๐˜ธ๐˜ธ๐˜ธ.๐˜ณ๐˜ฆ๐˜ฃ๐˜ณ๐˜ข๐˜ช๐˜ฏ.๐˜ฆ๐˜ถ ๐Ÿ”—https://lnkd.in/dt27iKXS #MDR #MedTech #DBS #Lesioning #Neurosurgery #AIinHealthcare #HealthTech #MachineLearning #Innovation #ParkinsonsDisease #EssentialTremor #RebrAIn #FDA #CE #PrecisionMedicine

Post content